BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  New nipocalimab data published in mAbs journal details differentiated molecular design, clinical profile and potential of nipocalimab to treat IgG-driven alloantibody and autoantibody diseases

  February 14, 2025

   · 

  7 min read
• Press Releases

  Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025

  February 14, 2025

   · 

  1 min read
• Press Releases

  Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress

  February 14, 2025

   · 

  19 min read
• Press Releases

  Genprex Collaborators Find NPRL2 Gene Therapy Using Oncoprex® Delivery System is a Potential Treatment for Anti-PD1 Resistant Non-Small Cell Lung Cancer

  February 14, 2025

   · 

  7 min read
• Press Releases

  IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share

  February 14, 2025

   · 

  17 min read
• Press Releases

  WhiteSwell Announces New Data Supporting Acute Decompensated Heart Failure Treatment with eLym System

  February 14, 2025

   · 

  6 min read
• Press Releases

  GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients

  February 14, 2025

   · 

  3 min read
• Press Releases

  ViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for APRETUDE for HIV-1 Pre-Exposure Prophylaxis

  February 14, 2025

   · 

  5 min read
• Press Releases

  CereVasc Receives Approval for STRIDE Clinical Trial of the eShunt® System for the Treatment of Elderly Patients with Normal Pressure Hydrocephalus in Argentina

  February 14, 2025

   · 

  3 min read
• Press Releases

  Roche Elecsys sFlt-1/PlGF ratio for preeclampsia receives FDA 510(k) clearance, offering a fast and reliable way to predict the risk of developing severe preeclampsia

  February 14, 2025

   · 

  8 min read